Lower than usual activity in a complex that recycles proteins in cells — called the proteosome —…
Steve Bryson, PhD
Steve holds a PhD in biochemistry from the Faculty of Medicine at the University of Toronto, Canada. As a medical scientist for 18 years, he worked in both academia and industry, where his research focused on the discovery of new vaccines and medicines to treat inflammatory disorders and infectious diseases. Steve is a published author in multiple peer-reviewed scientific journals and a patented inventor.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Steve Bryson, PhD
A survey of people with Parkinson’s disease in Iran found significantly higher levels of anxiety due to the…
An oxygen-free (anaerobic) formulation of dopamine infused directly into the brain of monkeys with induced Parkinson’s safely improved both…
Delivering a gene therapy directly to the substantia nigra, an area of the brain affected by …
An important signaling pathway that helps protect brain cells from neurodegenerative diseases such as Parkinson’s…
Placing electrodes directly in the brains of people with Parkinson’s disease revealed a…
More than one-third of older people with Parkinson’s disease in long-term care who…
A blood test may be able to predict early cognitive decline in people with Parkinson’s disease by…
A new potential target for treating Parkinson’s, a protein named Drp1, has been identified using a rat…
People with Parkinson’s disease reported a need for increased planning in their lives due to limited mobility and…